TONI CANIGLIA: Open Payments
NPI 1487650677 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 20 payments from 10 companies in 2025. Trend: 2023 $206 · 2024 $323 · 2025 $739
Food & beverage: $613Education: $99Travel & lodging: $27
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $315 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| BioCryst US Sales Co., LLC | 2 | $55 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $54 |
| GENZYME CORPORATION | 1 | $24 |
| Optinose US, Inc. | 1 | $22 |
| Ionis Pharmaceuticals, Inc. | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $17 |
Products named: BOTOX, DUPIXENT, ORLADEYO, NEFFY, Rhapsido, CUVITRU, TAKHZYRO, Xhance.
Industry payments across CA — which companies pay providers there.
